CHA Hospital opens ‘Global Infertility Center,’ using AI to address infertility challenges

-Asia’s largest facility launches in Magok, Seoul
-Leading infertility specialists join the team

CHA Hospital, regarded as one of the world’s leading infertility treatment centers, has opened the AI-Specialized Global Infertility Center (Magok CHA Hospital) in Magok, Seoul.

Having built Asia’s largest advanced infertility treatment system, CHA Hospital plans to integrate artificial intelligence into its 65 years of accumulated reproductive-medicine expertise to provide precision infertility care.

Located on the 7th floor of Le West City Tower A and B near Magoknaru Station, the center spans approximately 71,160 square feet (6,611 square meters). It includes nine consultation rooms, five operating rooms, an international-standard clean-room laboratory, and an AI-powered egg bank. Full medical services will begin on November 17.

The new center aims to establish a next-generation infertility treatment model by combining CHA Hospital’s vast reproductive-medicine database with AI technology and a patient-centered philosophy.

Treatment will incorporate AI-supported processes such as embryo grading, automated analysis of reproductive cells (sperm and eggs), implantation potential prediction, and supplementary analysis for pre-implantation genetic testing (PGT).

AI technology will also be applied to egg freezing, allowing the center to more precisely assess egg quality, determine the optimal freezing time, and predict the likelihood of viable embryo development after thawing—enhancing support for women seeking to preserve their fertility.

The medical team includes many of Korea’s top infertility specialists, such as Han Se-yeol, head of infertility services at CHA Hospital, and Moon Shin-yong, former Seoul National University professor who achieved Korea’s first IVF procedure. CHA Hospital noted that it has strengthened its precision treatment system by becoming the first infertility center to hire AI specialists.

Director Han is a leading expert in advanced maternal age pregnancy, reproductive cell preservation, laparoscopic and hysteroscopic surgery, and in-vitro maturation (IVM). In 1998, he contributed to the world’s first development of the vitrification egg-freezing method with the research team led by Cha Kwang-yul, head of CHA Hospital and CHA Bio Group’s global institute. Over 37 years, he has assisted more than 10,000 infertile couples in achieving pregnancy.

Joining as honorary director, Professor Moon Shin-yong spearheaded the birth of Korea’s first test-tube baby and has spent more than three decades advancing reproductive medicine research and clinical practice both domestically and internationally. Additional specialists from CHA’s Seoul Station Infertility Center—Yang Nu-ri, Yeom Sun-hyung, Lim Jung-mi, and Kim Ji-eun—as well as Jung Ja-yeon of Bundang CHA Hospital, will also participate in patient care at the Magok center.

To build its AI-based system, CHA Biotech executive Yoon Seok-hwan said the team aims to present “a new paradigm in infertility treatment by enhancing convenience across all stages of care and service through AI.”

Meanwhile, with its opening, Magok CHA Hospital has introduced Korea’s first infertility-center-specialized ‘KareChat’ service. KareChat is a smart healthcare platform on KakaoTalk—requiring no additional app installation—that allows patients to make appointments, adjust schedules, and access infertility education content. It enables patients to easily check essential information before visits and efficiently manage personalized treatment plans.

BY KYEONGJUN KIM  [kim.kyeongjun@koreadaily.com]